Cardno Limited
Cardno Limited (CDD.AX) Financial Performance & Income Statement Overview
Explore the financials of Cardno Limited (CDD.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Cardno Limited (CDD.AX) Income Statement & Financial Overview
Explore comprehensive income reports for Cardno Limited CDD.AX, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $4.12M | $4.27M | $4.50M | $6.43M |
| Cost of Revenue | $8.36M | -$574000.00 | $2.31M | $5.74M |
| Gross Profit | -$4.24M | $4.84M | $2.19M | $682000.00 |
| Gross Profit Ratio | -$1.03 | $1.13 | $0.49 | $0.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.71M | -$1.72M | -$275000.00 | $4.35M |
| Operating Expenses | $1.20M | -$2.10M | -$402000.00 | $4.29M |
| Total Costs & Expenses | $9.56M | -$2.67M | $1.91M | $10.03M |
| Interest Income | $591000.00 | $189000.00 | $194000.00 | $167000.00 |
| Interest Expense | $5000.00 | $22000.00 | $7000.00 | $13000.00 |
| Depreciation & Amortization | $105000.00 | $112000.00 | $104000.00 | $109000.00 |
| EBITDA | $1.10M | $7.02M | $2.69M | -$3.03M |
| EBITDA Ratio | $0.27 | $1.65 | $0.60 | -$0.54 |
| Operating Income | -$5.44M | $6.94M | $2.59M | -$3.60M |
| Operating Income Ratio | -$1.32 | $1.63 | $0.58 | -$0.56 |
| Other Income/Expenses (Net) | $6.42M | -$54000.00 | $624000.00 | $456000.00 |
| Income Before Tax | $986000.00 | $6.89M | $3.21M | -$3.15M |
| Income Before Tax Ratio | $0.24 | $1.61 | $0.71 | -$0.49 |
| Income Tax Expense | -$2000.00 | $332000.00 | $9000.00 | $670000.00 |
| Net Income | $988000.00 | $7.16M | $2.41M | -$3.02M |
| Net Income Ratio | $0.24 | $1.68 | $0.53 | -$0.47 |
| EPS | $0.03 | $0.18 | $0.06 | -$0.08 |
| Diluted EPS | $0.03 | $0.18 | $0.06 | -$0.08 |
| Weighted Avg Shares Outstanding | $39.06M | $39.06M | $39.06M | $39.06M |
| Weighted Avg Shares Outstanding (Diluted) | $39.06M | $39.06M | $39.06M | $39.06M |
Over the past four quarters, Cardno Limited demonstrated steady revenue growth, increasing from $6.43M in Q2 2023 to $4.12M in Q4 2024. Operating income reached -$5.44M in Q4 2024, maintaining a consistent -132% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.10M, reflecting operational efficiency. Net income dropped to $988000.00, with EPS at $0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan